CBPO on NASDAQ

China Biologic Products, Inc.

Chinese pharmaceutical company

China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province.³ From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

TickerCBPO on NASDAQ¹
Industrybiotechnology¹
HeadquartersBeijing¹
Websitechinabiologic.com
Business address18Th Fl, Jialong Internationalbuilding, 19 Chaoyang Park Road, Chaoyang District, Beijing, F4 100125⁴
Filer categoryLarge accelerated filer⁴

See how the biggest companies compare on our leaderboards

The story

The company is engaged in the research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other healthcare facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.

Previously listed on Nasdaq, in April 2021, it was taken private in a $4.6 billion deal by an investor group that included Centurium Capital, CITIC Capital and Hillhouse Capital.

From Wikipedia’s article on China Biologic Products, shared under CC BY-SA 4.0.⁵

Leadership

Who has led China Biologic Products, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chao Ming Zhao2012

Chief financial officer

2010201520202025

Chief executive officerDavid Gao May 14, 2012 to Mar 2, 2017⁶
Chief executive officerChao Ming Zhao Dec 14, 2009 to Sep 9, 2010⁷
Chief executive officerCbpo Stanley Wong Sep 13, 2007 to May 16, 2008⁸
PresidentChao Ming Zhao Nov 30, 2012 to Nov 30, 2012⁹
Chief financial officerYuyun Tristan Kuo Jun 5, 2008 to Dec 14, 2011¹⁰
Chief financial officerChao Ming Zhao Sep 12, 2007 to May 16, 2008¹¹

Board members and other officers (22)

Vice PresidentZhijing Cbpo Liu Apr 29, 2013 to May 10, 2017¹²
Corporate Vice PresidentGang Cbpo Yang Aug 26, 2013 to Aug 17, 2016¹³
DCTR CONTROLLING SHAREHOLDERLing Siu Chan Sep 12, 2007 to Sep 12, 2007¹⁴
Board memberMin Fang Mar 12, 2015 to Aug 12, 2016¹⁵
Board memberDai Feng May 9, 2014 to May 9, 2014¹⁶
Board memberYungang Lu Mar 23, 2012 to Aug 8, 2016¹⁷
Board memberHan Zhang Apr 30, 2012 to Apr 30, 2012¹⁸
Board memberZhijun Tong Apr 30, 2012 to Aug 8, 2016¹⁹
Board memberLe Zhang Oct 1, 2012 to Aug 20, 2013²⁰
Board memberChong Yang Li Jan 28, 2011 to Jan 28, 2011²¹
Board memberWenfang Liu Mar 18, 2011 to Aug 17, 2016²²
Board memberPincus X. L.p. Warburg May 24, 2011 to Jun 8, 2016²³
Board memberDavid Gao Nov 15, 2011 to Mar 2, 2017²⁴
Board memberJoseph Landy Dec 1, 2011 to May 15, 2013²⁵
Board memberXiangmin Cui Mar 26, 2010 to Jan 28, 2011²⁶
Board memberGuang Li Pang May 16, 2008 to May 16, 2008²⁷
Board memberLin Ling Li May 16, 2008 to Dec 14, 2010²⁸
Board memberSean Shao Aug 18, 2008 to Mar 3, 2017²⁹
Board memberTong Jun Lin Aug 20, 2008 to Jan 28, 2011³⁰
Board memberJie Gan Sep 10, 2008 to Sep 10, 2008³¹
Board memberChao Ming Zhao Sep 12, 2007 to Jun 29, 2010¹¹
Board memberLing Siu Chan Sep 12, 2007 to Dec 14, 2010¹⁴

Timeline

May 14, 2012New chief executive David Gao becomes CEO⁶
Dec 14, 2009New chief executive Chao Ming Zhao becomes CEO⁷
Sep 13, 2007New chief executive Cbpo Stanley Wong becomes CEO⁸
Apr 3, 2007Went public Listed on NASDAQ¹

Filings

3 filings to the SEC since October 2021: 1 large holders, 2 other. The latest 3:

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

1 such filings since October 2021:

May 12, 2023SC 13D/A

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataChina Biologic Products, Inc. on Wikidata
2
SEC EDGARChina Biologic Products, Inc. filings on SEC EDGAR
3
WikipediaChina Biologic Products, Inc. on Wikipedia
4
SEC EDGARChina Biologic Products, Inc. filings on SEC EDGAR
5
WikipediaChina Biologic Products, Inc. on Wikipedia (revision used)
6
SEC EDGARDavid Gao, Chief executive officer
7
SEC EDGARChao Ming Zhao, Chief executive officer
8
SEC EDGARCbpo Stanley Wong, Chief executive officer
9
SEC EDGARChao Ming Zhao, President
10
SEC EDGARYuyun Tristan Kuo, Chief financial officer
11
SEC EDGARChao Ming Zhao, Chief financial officer
12
SEC EDGARZhijing Cbpo Liu, Vice President
13
SEC EDGARGang Cbpo Yang, Corporate Vice President
14
SEC EDGARLing Siu Chan, DCTR CONTROLLING SHAREHOLDER
15
SEC EDGARMin Fang, Board member
16
SEC EDGARDai Feng, Board member
17
SEC EDGARYungang Lu, Board member
18
SEC EDGARHan Zhang, Board member
19
SEC EDGARZhijun Tong, Board member
20
SEC EDGARLe Zhang, Board member
21
SEC EDGARChong Yang Li, Board member
22
SEC EDGARWenfang Liu, Board member
23
SEC EDGARPincus X. L.p. Warburg, Board member
24
SEC EDGARDavid Gao, Board member
25
SEC EDGARJoseph Landy, Board member
26
SEC EDGARXiangmin Cui, Board member
27
SEC EDGARGuang Li Pang, Board member
28
SEC EDGARLin Ling Li, Board member
29
SEC EDGARSean Shao, Board member
30
SEC EDGARTong Jun Lin, Board member
31
SEC EDGARJie Gan, Board member